» Articles » PMID: 32007505

Host DNA Depletion Efficiency of Microbiome DNA Enrichment Methods in Infected Tissue Samples

Overview
Specialty Microbiology
Date 2020 Feb 3
PMID 32007505
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Shotgun metagenomic sequencing or metagenomic whole genome sequencing is a genome-wide sequencing approach to explore bacterial communities directly from their habitat or sites of infection. However, host DNA contamination in metagenomic sequencing overwhelm low biomass of microbial signals and decrease sensitivity for microbial detection. In this study, we evaluated the host DNA depletion efficiency of four different microbiome DNA enrichment methods (NEBNext Microbiome DNA Enrichment kit, Molzym Ultra-Deep Microbiome Prep, QIAamp DNA Microbiome kit and Zymo HostZERO microbial DNA kit) in diabetic foot infection (DFI) tissue samples using quantitative real-time PCR and their effect on bacterial community composition by 16S ribosomal RNA amplicon sequencing. The host DNA depletion ratio (18S/16S rRNA), the percentage of bacterial DNA component and the microbial community profile of DFI were compared before (control) and after each microbiome DNA enrichment method. There was a significant difference in the 18S/16S rRNA ratio among different microbiome DNA enrichment methods (p <.001). QIAamp and HostZERO method reduced 18S/16S rRNA ratio by 32 and 57 fold than control method respectively. The percentage of bacterial DNA component increased more than ten-fold in QiaAmp (71.0 ± 2.7%) and HostZERO (79.9 ± 3.1%) method respectively than those in control method without host DNA depletion (6.7 ± 0.1%). It demonstrated the host DNA contamination was efficiently depleted and bacterial DNA was effectively enriched in HostZERO and QIAamp methods, attesting to the efficacy of these two methods in shotgun metagenomic sequencing studies. Overall, bacterial community composition of DFI samples was similar between control and microbiome enriched DNA samples.

Citing Articles

Applying 3D cultures and high-throughput technologies to study host-pathogen interactions.

De Martinis E, Alves V, Pereira M, Andrade L, Abichabki N, Abramova A Front Immunol. 2025; 16:1488699.

PMID: 40051624 PMC: 11882522. DOI: 10.3389/fimmu.2025.1488699.


Benchmarking short-read metagenomics tools for removing host contamination.

Gao Y, Luo H, Lyu H, Yang H, Yousuf S, Huang S Gigascience. 2025; 14.

PMID: 40036691 PMC: 11878760. DOI: 10.1093/gigascience/giaf004.


Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters.

Schwenger K, Copeland J, Ghorbani Y, Chen L, Comelli E, Guttman D Microbiome. 2025; 13(1):9.

PMID: 39810228 PMC: 11730849. DOI: 10.1186/s40168-024-02004-7.


Rapid and accurate testing for urinary tract infection: new clothes for the emperor.

Moreland R, Brubaker L, Tinawi L, Wolfe A Clin Microbiol Rev. 2024; 38(1):e0012924.

PMID: 39641639 PMC: 11905368. DOI: 10.1128/cmr.00129-24.


Host DNA depletion on frozen human respiratory samples enables successful metagenomic sequencing for microbiome studies.

Kim M, Parrish 2nd R, Tisza M, Shah V, Tran T, Ross M Commun Biol. 2024; 7(1):1590.

PMID: 39609616 PMC: 11604929. DOI: 10.1038/s42003-024-07290-3.